173 related articles for article (PubMed ID: 36813266)
1. Opioid research in the time of the opioid crisis.
Traynor JR; Moron JA
Br J Pharmacol; 2023 Apr; 180(7):793-796. PubMed ID: 36813266
[TBL] [Abstract][Full Text] [Related]
2. Emerging areas of opioid pharmacology.
Kelly E; Henderson G; Bailey CP
Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
[TBL] [Abstract][Full Text] [Related]
3. Insights into the mechanisms underlying opioid use disorder and potential treatment strategies.
Cao DN; Li F; Wu N; Li J
Br J Pharmacol; 2023 Apr; 180(7):862-878. PubMed ID: 34128238
[TBL] [Abstract][Full Text] [Related]
4. The anomalous pharmacology of fentanyl.
Kelly E; Sutcliffe K; Cavallo D; Ramos-Gonzalez N; Alhosan N; Henderson G
Br J Pharmacol; 2023 Apr; 180(7):797-812. PubMed ID: 34030211
[TBL] [Abstract][Full Text] [Related]
5. Strategies towards safer opioid analgesics-A review of old and upcoming targets.
Varga BR; Streicher JM; Majumdar S
Br J Pharmacol; 2023 Apr; 180(7):975-993. PubMed ID: 34826881
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities.
Gaborit M; Massotte D
Br J Pharmacol; 2023 Apr; 180(7):994-1013. PubMed ID: 34883528
[TBL] [Abstract][Full Text] [Related]
7. Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.
Lee MT; Mackie K; Chiou LC
Br J Pharmacol; 2023 Apr; 180(7):894-909. PubMed ID: 34877650
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders.
Alvarez-Perez B; Poras H; Maldonado R
Br J Pharmacol; 2023 Apr; 180(7):879-893. PubMed ID: 34378790
[TBL] [Abstract][Full Text] [Related]
9. Understanding and countering opioid-induced respiratory depression.
Bateman JT; Saunders SE; Levitt ES
Br J Pharmacol; 2023 Apr; 180(7):813-828. PubMed ID: 34089181
[TBL] [Abstract][Full Text] [Related]
10. The dynamic interaction between pain and opioid misuse.
Wilson-Poe AR; Morón JA
Br J Pharmacol; 2018 Jul; 175(14):2770-2777. PubMed ID: 28602044
[TBL] [Abstract][Full Text] [Related]
11. Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects.
López-Cano M; Font J; Aso E; Sahlholm K; Cabré G; Giraldo J; De Koninck Y; Hernando J; Llebaria A; Fernández-Dueñas V; Ciruela F
Br J Pharmacol; 2023 Apr; 180(7):958-974. PubMed ID: 34363210
[TBL] [Abstract][Full Text] [Related]
12. A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinase.
Groom S; Blum NK; Conibear AE; Disney A; Hill R; Husbands SM; Li Y; Toll L; Kliewer A; Schulz S; Henderson G; Kelly E; Bailey CP
Br J Pharmacol; 2023 Apr; 180(7):943-957. PubMed ID: 33245558
[TBL] [Abstract][Full Text] [Related]
13. Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia.
Pisanò CA; Mercatelli D; Mazzocchi M; Brugnoli A; Morella I; Fasano S; Zaveri NT; Brambilla R; O'Keeffe GW; Neubig RR; Morari M
Br J Pharmacol; 2023 Apr; 180(7):927-942. PubMed ID: 34767639
[TBL] [Abstract][Full Text] [Related]
14. Editorial for GPR84 pharmacology.
Milligan G
Br J Pharmacol; 2024 May; 181(10):1497-1499. PubMed ID: 38456201
[TBL] [Abstract][Full Text] [Related]
15. Targeting multiple opioid receptors - improved analgesics with reduced side effects?
Günther T; Dasgupta P; Mann A; Miess E; Kliewer A; Fritzwanker S; Steinborn R; Schulz S
Br J Pharmacol; 2018 Jul; 175(14):2857-2868. PubMed ID: 28378462
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin and opioid addiction revisited: old drug, new applications.
Zanos P; Georgiou P; Weber C; Robinson F; Kouimtsidis C; Niforooshan R; Bailey A
Br J Pharmacol; 2018 Jul; 175(14):2809-2824. PubMed ID: 28378414
[TBL] [Abstract][Full Text] [Related]
17. Metabolic interactions of benzodiazepines with oxycodone ex vivo and toxicity depending on usage patterns in an animal model.
Lawson R; Čechová P; Zarrouk E; Javellaud J; Bazgier V; Otyepka M; Trouillas P; Picard N; Marquet P; Saint-Marcoux F; El Balkhi S
Br J Pharmacol; 2023 Apr; 180(7):829-842. PubMed ID: 34855983
[TBL] [Abstract][Full Text] [Related]
18. Central metabolism as a potential origin of sex differences in morphine antinociception but not induction of antinociceptive tolerance in mice.
Gabel F; Hovhannisyan V; Andry V; Goumon Y
Br J Pharmacol; 2023 Apr; 180(7):843-861. PubMed ID: 34986502
[TBL] [Abstract][Full Text] [Related]
19. Fifteen years of Na
Eagles DA; Chow CY; King GF
Br J Pharmacol; 2022 Jul; 179(14):3592-3611. PubMed ID: 33206998
[TBL] [Abstract][Full Text] [Related]
20. Highlights into the pharmacology of nutraceuticals.
Andrew R; Izzo AA
Br J Pharmacol; 2020 Mar; 177(6):1209-1211. PubMed ID: 32133625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
